Emblaveo will be available in the third quarter of 2025 to treat patients with intra-abdominal infections, a common cause of sepsis in the intensive care unit.

As a result of President Donald Trump 's freeze on foreign aid, a map of African countries shows where a drop in HIV funding could have an impact. A global surge in infections is predicted if U.S.

Pune: The western Indian city of Pune is seeing an unusually large cluster of cases of a paralysing neurological disorder, in ...

Addresses the significant threat of antimicrobial resistance.

A sore throat usually isn't serious enough for a trip to the doctor, and many natural remedies can help ease your symptoms, ...

An expert briefly describes the study ‘Single Dose Aminoglycosides versus Carbapenems for the Treatment of Uncomplicated ...

An expert briefly describes the study ‘Single Dose Aminoglycosides versus Carbapenems for the Treatment of Uncomplicated Urinary Tract Infections Caused by Extended-Spectrum β-lactamase-phenotype Gram ...

More than 125 million people worldwide suffer from some form of psoriasis. If you’ve struggled with your skin health this ...

Roorkee have uncovered a crucial regulatory mechanism in Acinetobacter baumannii -- a highly drug-resistant superbug ...

Learn the real causes behind uncontrollable coughing and discover effective treatments from medical experts, plus warning ...

Regular health screenings play a crucial role in maintaining overall well-being. An STD test in Gurgaon helps detect sexually ...

AbbVie has received US Food and Drug Administration (FDA) approval for Emblaveo (aztreonam and avibactam) to be used in ...